This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schulz, U. Articles by Boemke, W. Search for Related Content PubMed Articles by Schulz, U. Articles by Boemke, W. Related Collections Neuroanesthesia Anesthetic Techniques Monitoring (Non-cardiac)

---

NEUROSURGICAL ANESTHESIA

Bispectral Index Monitoring Does Not Improve Anesthesia Performance in Patients with Movement Disorders Undergoing Deep Brain Stimulating Electrode Implantation

Uwe Schulz, MD^*, Didier Keh, MD, Christoph Barner, MD, Udo Kaisers, MD, and Willehad Boemke, MD

From the *Department of Critical Care, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates; Department of Anesthesiology and Surgical Intensive Care Medicine, Charité—Universitaetsmedizin Berlin, Campus Virchow Klinikum and Campus Charité Mitte, Berlin, Germany; and Department of Anesthesiology and Intensive Care Medicine, Universitaet Leipzig, Leipzig, Germany.

Address correspondence and reprint requests to Willehad Boemke, MD, Klinik für Anästhesiologie und Operative Intensivmedizin, Campus Virchow Klinikum, Charité—Universitätsmedizin Berlin, Augustenburger Platz 1, D-13353 Berlin, Germany. Address e-mail to willehad.boemke{at}charite.de.

BACKGROUND: Deep brain stimulation (DBS) has emerged as a promising therapy for movement disorders. During the implantation procedure for the electrodes, the patient emerges from anesthesia repeatedly to facilitate neurological testing. We investigated whether Bispectral Index (BIS ^TM) monitoring would be beneficial in patients receiving "sleep-awake-sleep" anesthesia with respect to time of arousal, consumption of propofol, and cardiopulmonary stability (i.e., heart rate, arterial blood pressure, and end-tidal carbon dioxide).

METHODS: We investigated 21 patients scheduled for implantation of DBS electrodes. Depth of propofol anesthesia was controlled either with BIS guidance in 10 patients (BIS group) or without in 11 patients (non-BIS group). In the BIS group, a BIS score of 40–60 was targeted during sleep periods, whereas in the non-BIS group, a value of 1 (= no response to tactile stimulation [unconsciousness]) on the Observers’ Assessment of Alertness/Sedation Scale was targeted. For analgesia, the sites for the burr holes and for the pins of the stereotactic ring were infiltrated with 2% lidocaine; no opioids were used. For periods during which an awake patient required neurological testing, propofol was discontinued.

RESULTS: We found no difference between groups with respect to times of arousal, total amount of propofol consumption, and cardiopulmonary stability. However, significantly more propofol boluses had to be administered in the BIS group (30 ± 11.6 vs 17 ± 4.6) to maintain the BIS score within the target range (P < 0.05).

CONCLUSION: BIS monitoring does not improve anesthesia management for DBS electrode implantation in patients with movement disorders.

This article has been cited by other articles:

				C. C. M. Poon and M. G. Irwin Anaesthesia for deep brain stimulation and in patients with implanted neurostimulator devices Br. J. Anaesth., August 1, 2009; 103(2): 152 - 165. [Abstract] [Full Text] [PDF]